![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Alzheimer's Disease |
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Amyloid-beta oligomers increase the binding and internalization of tau oligomers in
human synapses.
Acta Neuropathol. 2024;149:2.
PubMed
Abstract available
Alzheimer's disease-associated CD83(+) microglia are linked with increased
immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain.
Alzheimers Dement. 2024 Dec 19. doi: 10.1002/alz.14401.
PubMed
Abstract available
Sex-specific mechanisms of cerebral microvascular BK(Ca) dysfunction in a mouse
model of Alzheimer's disease.
Alzheimers Dement. 2024 Dec 19. doi: 10.1002/alz.14438.
PubMed
Abstract available
Defining benefit: Clinically and biologically meaningful outcomes in the
next-generation Alzheimer's disease clinical care pathway.
Alzheimers Dement. 2024 Dec 19. doi: 10.1002/alz.14425.
PubMed
Abstract available
Transethnic analysis identifies SORL1 variants and haplotypes protective against
Alzheimer's disease.
Alzheimers Dement. 2024 Dec 10. doi: 10.1002/alz.14214.
PubMed
Abstract available
Appropriate use of meaningful within-patient change (MWPC) thresholds in
Alzheimer's disease.
Alzheimers Dement. 2024 Dec 18. doi: 10.1002/alz.14436.
PubMed
Am J Alzheimers Dis Other Demen
A Study on Machine Learning Models in Detecting Cognitive Impairments in
Alzheimer's Patients Using Cerebrospinal Fluid Biomarkers.
Am J Alzheimers Dis Other Demen. 2024;39:15333175241308645.
PubMed
Abstract available
Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia:
Clinical Uncertainties and the Path Forward.
Am J Geriatr Psychiatry. 2024 Nov 19:S1064-7481(24)00533.
PubMed
Abstract available
Brain Metabolic Resilience in Alzheimer's Disease: A Predictor of Cognitive
Decline and Conversion to Dementia.
Am J Geriatr Psychiatry. 2024 Dec 3:S1064-7481(24)00543.
PubMed
Abstract available
Do Caregivers Value the New Antiamyloid Treatments for Alzheimer's Disease More
Than Home-Based Care?
Am J Geriatr Psychiatry. 2024 Nov 26:S1064-7481(24)00541.
PubMed
Abstract available
Exploring the gut-brain axis in alzheimer's disease treatment via probiotics:
evidence from animal studies-a systematic review and meta-analysis.
BMC Neurol. 2024;24:481.
PubMed
Abstract available
A case report about focal status epilepticus as first presentation in Alzheimer's
disease: finding the culprit.
BMC Neurol. 2024;24:478.
PubMed
Abstract available
Alzheimer's disease mortality among taxi and ambulance drivers: population based
cross sectional study.
BMJ. 2024;387:e082194.
PubMed
Abstract available
Amyloid-beta-activated microglia can induce compound proteinopathies.
Brain. 2024;147:4105-4120.
PubMed
Abstract available
Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer's,
vascular and Lewy body dementias.
Brain. 2024 Dec 9:awae388. doi: 10.1093.
PubMed
Abstract available
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head
comparison.
Brain. 2024 Dec 16:awae368. doi: 10.1093.
PubMed
Abstract available
T-regulatory cells and extracellular vesicles in Alzheimer's disease: New
therapeutic concepts and hypotheses.
Brain Res. 2024;1850:149393.
PubMed
Abstract available
Potential molecular mechanisms of tobacco smoke exposure in Alzheimer's disease.
Brain Res. 2024;1848:149394.
PubMed
Abstract available
Using Entropy as the Convergence Criteria of Ant Colony Optimization and the
Application at Gene Chip Data Analysis.
Curr Alzheimer Res. 2025;21:324-341.
PubMed
Abstract available
Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits
of a Defined Ginkgo Biloba Extract for Adults with Major Neurocognitive Disorder.
Dement Geriatr Cogn Disord. 2024;53:299-309.
PubMed
Abstract available
The biological roots of the sex-frailty paradox.
Exp Gerontol. 2024;198:112619.
PubMed
Abstract available
Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and
exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease
in aged mice.
Exp Gerontol. 2024;199:112659.
PubMed
Abstract available
Pharmacological PTP1B inhibition rescues motor learning, neuroinflammation, and
hyperglycaemia in a mouse model of Alzheimer's disease.
Exp Neurol. 2024;385:115115.
PubMed
Abstract available
Tri-culture modeling of neuroinflammation, neurodegeneration, and
neuroprotection.
J Alzheimers Dis. 2024;102:742-744.
PubMed
Abstract available
The association between oral diseases and neurodegenerative disorders.
J Alzheimers Dis. 2024;102:577-586.
PubMed
Abstract available
Technology literacy and access to digital resources for remote assessment among
adults enrolled in Alzheimer's disease research.
J Alzheimers Dis. 2024 Dec 11:13872877241297496. doi: 10.1177/13872877241297496.
PubMed
Abstract available
Associating faces with names and meals as a biomarker of early AD in cognitively
healthy individuals.
J Alzheimers Dis. 2024;102:639-641.
PubMed
Abstract available
Benefits of nostalgic landmarks for people living with Alzheimer's disease.
J Alzheimers Dis. 2024;102:683-702.
PubMed
Abstract available
Reactions of clinical neuropsychologists to the Alzheimer's Association
workgroup's draft diagnostic and staging criteria for Alzheimer's disease.
J Alzheimers Dis. 2024;102:877-884.
PubMed
Abstract available
Reporting of comorbidities and health status of participants in clinical trials
testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease:
A systematic review.
J Alzheimers Dis. 2024;102:587-596.
PubMed
Abstract available
Differences in lean mass and sarcopenia between individuals with Alzheimer's
disease and those without dementia: A systematic review and meta-analysis of
observational studies.
J Alzheimers Dis. 2024 Dec 16:13872877241299051. doi: 10.1177/13872877241299051.
PubMed
Abstract available
Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the
hippocampus in an ischemic model of Alzheimer's disease with survival up to 2
years.
J Alzheimers Dis. 2024 Dec 16:13872877241303950. doi: 10.1177/13872877241303950.
PubMed
Abstract available
Associations between antidiabetic medications and cerebrospinal fluid biomarkers
of Alzheimer's disease.
J Alzheimers Dis. 2024 Dec 16:13872877241304995. doi: 10.1177/13872877241304995.
PubMed
Abstract available
Long-term safety of gantenerumab in participants with Alzheimer's disease: A
phase III, open-label extension study (SCarlet RoAD).
J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644.
PubMed
Abstract available
Exploratory study of French healthcare workers' experiences of anosognosia in
Alzheimer's disease and related disorders.
J Alzheimers Dis. 2024 Dec 19:13872877241307045. doi: 10.1177/13872877241307045.
PubMed
Abstract available
Anti-amyloid treatments for Alzheimer's disease: A study on physicians'
perspectives.
J Alzheimers Dis. 2024;102:627-632.
PubMed
Abstract available
Missense Mutations of the Ephrin Receptor EPHA1 Associated with Alzheimer's
Disease Disrupt Receptor Signaling Functions.
J Biol Chem. 2024 Dec 18:108099. doi: 10.1016/j.jbc.2024.108099.
PubMed
Abstract available
Testing cognitive normal for Alzheimer's disease prediction.
J Neurochem. 2025;169:e16272.
PubMed
Abstract available
Preferential clustering of microglia and astrocytes around neuritic plaques
during progression of Alzheimer's disease neuropathological changes.
J Neurochem. 2025;169:e16275.
PubMed
Abstract available
Identification of Alzheimer's disease susceptibility genes by integrating eight
human brain single-cell transcriptomes with genome-wide association studies.
J Neurochem. 2025;169:e16276.
PubMed
Abstract available
EXPRESSION OF CONCERN: Potent Anti-amyloidogenic and Fibril-destabilizing Effects
of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of
Alzheimer's Disease.
J Neurochem. 2025;169:e16285.
PubMed
Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and
synaptic and memory impairments in 3xTg-AD mice.
J Neurochem. 2025;169:e16215.
PubMed
Abstract available
Altered metabolic function induced by Abeta-oligomers and PSEN1 mutations in
iPSC-derived astrocytes.
J Neurochem. 2025;169:e16267.
PubMed
Abstract available
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined
young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.
J Neurol. 2024;272:25.
PubMed
Abstract available
Recognition memory decline is associated with the progression to prodromal
Alzheimer's disease in asymptomatic at-risk individuals.
J Neurol. 2024;272:70.
PubMed
Abstract available
Brain MRI volumetry and atrophy rating scales as predictors of amyloid status and
eligibility for anti-amyloid treatment in a real-world memory clinic setting.
J Neurol. 2024;272:84.
PubMed
Abstract available
Telomere length, in vivo Alzheimer's disease pathologies and cognitive decline in
older adults.
J Neurol Neurosurg Psychiatry. 2024 Dec 12:jnnp-2024-334314.
PubMed
Abstract available
How well do plasma Alzheimer's disease biomarkers reflect the CSF amyloid status?
J Neurol Neurosurg Psychiatry. 2024 Dec 18:jnnp-2024-334122.
PubMed
Abstract available
The Challenges of Modulating Neuroinflammation in Alzheimer's Disease and
Multiple Sclerosis with TREM2 Agonistic Antibodies.
J Neurosci. 2024;44:e1869242024.
PubMed
Bridging the diagnostic gap in Alzheimer's disease.
Lancet Neurol. 2025;24:1.
PubMed
Brain clocks capture diversity and disparities in aging and dementia across
geographically diverse populations.
Nat Med. 2024;30:3646-3657.
PubMed
Abstract available
Study design features increase replicability in brain-wide association studies.
Nature. 2024;636:719-727.
PubMed
Abstract available
Procognitive and neurotrophic benefits of alpha5-GABA-A receptor positive allosteric
modulation in a beta-amyloid deposition mouse model of Alzheimer's disease
pathology.
Neurobiol Aging. 2024;147:49-59.
PubMed
Abstract available
Modeling functional loss in Alzheimer's Disease through cognitive reserve and
cognitive state: A panel data longitudinal study.
Neurobiol Aging. 2024;147:60-67.
PubMed
Abstract available
Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in
Alzheimer's 5XFAD Mice.
Neurochem Res. 2024;50:57.
PubMed
Abstract available
Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down
Syndrome: A Case Report.
Neurology. 2025;104:e210179.
PubMed
Abstract available
Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain
Atrophy in Patients With Alzheimer Disease and Seizures.
Neurology. 2025;104:e210173.
PubMed
Medical Histories Associated With Absence of Alzheimer Disease Neuropathologic
Changes in the Oldest-Old: The 90+ Study.
Neurology. 2025;104:e210107.
PubMed
Abstract available
Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of
Nicotinamide in Early Alzheimer Disease.
Neurology. 2025;104:e210152.
PubMed
Abstract available
Risk factors and predictive models in the progression from MCI to Alzheimer's
disease.
Neuroscience. 2024;565:312-319.
PubMed
Abstract available
Ginsenoside Rg1 attenuates Abeta(1-42)-induced microglial cell apoptosis and
inflammation in Alzheimer's disease via the GATA4/PDE4A/PI3K/AKT axis.
Neuroscience. 2024;565:377-385.
PubMed
Abstract available
"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological
Perspective".
Neuroscience. 2024;565:499-518.
PubMed
Abstract available
Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human
medial temporal lobe in Alzheimer's disease.
Neuroscience. 2024 Dec 16:S0306-4522(24)00734.
PubMed
Abstract available
Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and
anti-Alzheimer's drug discovery.
PLoS One. 2024;19:e0316010.
PubMed
Abstract available
Structure-based virtual screening of Trachyspermum ammi metabolites targeting
acetylcholinesterase for Alzheimer's disease treatment.
PLoS One. 2024;19:e0311401.
PubMed
Abstract available
Random survival forest model for early prediction of Alzheimer's disease
conversion in early and late Mild cognitive impairment stages.
PLoS One. 2024;19:e0314725.
PubMed
Abstract available
Resting-state EEG microstate features for Alzheimer's disease classification.
PLoS One. 2024;19:e0311958.
PubMed
Abstract available
Effects of rivastigmine on gait in patients with neurodegenerative disorders: A
systematic review and meta-analysis.
PLoS One. 2024;19:e0310900.
PubMed
Abstract available
Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in
adults with Down's syndrome.
PLoS One. 2024;19:e0311878.
PubMed
Abstract available
GSK3beta phosphorylation catalyzes the aggregation of tau into Alzheimer's
disease-like filaments.
Proc Natl Acad Sci U S A. 2024;121:e2414176121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.